Collecting Miracles

A friend of mine underwent cancer treatment not long ago and one of the things he did was collect stories of people who underwent very difficult circumstances and yet persevered.
Remember the story of hiker Aron Ralston, whose arm was caught in a boulder and he managed to save his own life by cutting off his own hand? Part of his success, as detailed in his book, “Between a Rock and a Hard Place,” was imagining himself as the father of a son, doing activities with him. His wish is about to come true, as his son is now due on Valentine’s Day. Imagining his own successful outcome now serves as a source of encouragement to others.
As does the story of the plane that landed in the Hudson River last year. One couple met on a plane briefly, then after their harrowing ordeal (I’ve always wanted to write that), fell in love and are now engaged. People magazine chronicles their story as a way to encourage others.
If you need encouragement, start your own collection of “miracle” stories. Not just from people who survived the same ordeal you have, but of those who faced difficulty and triumphed.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap